Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 1/2 1

Status

Completed 30Terminated 8Recruiting 7Unknown 5Active not recruiting 5Withdrawn 3Suspended 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Tumor-Agnostic 2Thoracic 2Gynecologic 1

Conditions

Breast Neoplasms 49Stomach Neoplasms 11Neoplasms 10HER2-positive Breast Cancer 8Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Neoplasms 5Triple Negative Breast Neoplasms 4Salivary Gland Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma 3Squamous Cell Carcinoma of Head and Neck 2Pathologic Complete Response 2Pancreatic Neoplasms 2Multiple Myeloma 2Meningeal Neoplasms 2Lymphoma, Non-Hodgkin 2Hematologic Neoplasms 2HER2-positive Early Breast Cancer 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Urinary Bladder Neoplasms 1Skin Neoplasms 1Resectable HER2-positive Breast Cancer 1Rectal Neoplasms 1

Interventions

pembrolizumab 49Specimen Handling 29Magnetic Resonance Spectroscopy 25Biopsy 25Radiosurgery 17Gemcitabine 17Nivolumab 16Cyclophosphamide 14Cisplatin 14Paclitaxel 13Carboplatin 13Bevacizumab 13Leucovorin 11Irinotecan 11Fluorouracil 11Drug Therapy 11Taxes 10Radiotherapy 10Oxaliplatin 10Capecitabine 10trastuzumab deruxtecan 9fludarabine 9cemiplimab 8Doxorubicin 8Cetuximab 8abemaciclib 7Trastuzumab 7Pemetrexed 7Fulvestrant 7Docetaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Metastasis × Trastuzumab × Clear all
NCT07007559 2026-06-05

ASPEN-09-03

ALX Oncology Inc.

Phase 2 Recruiting
120 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04802759 2026-05-11

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Hoffmann-La Roche

Phase 1/2 Recruiting
316 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06625775 2026-04-13

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Phase 1 Recruiting
392 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT05143970 2026-03-20

CHANCES

Institut Paoli-Calmettes

Phase 1 Recruiting
27 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07193394 2026-02-23

H3RAKLES

Institut Curie

Phase 2 Recruiting
20 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05525858 2025-04-27

KOSMOSII

Seoul National University Bundang Hospital

Recruiting
1,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06121700 2023-11-08

Miracle-G

Fudan University

Phase 2 Recruiting
55 enrolled
Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡